US Physical Therapy Inc (USPH) is a publicly traded Healthcare sector company. As of May 21, 2026, USPH trades at $62.16 with a market cap of $989.83M and a P/E ratio of 121.46. USPH moved +0.99% today. Year to date, USPH is -26.12%; over the trailing twelve months it is -21.61%. Its 52-week range spans $58.19 to $101.20. Analyst consensus is strong buy with an average price target of $97.50. Rallies surfaces USPH's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
USPH financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. USPH recently traded at $62.16. Market cap is $989.83M. P/E ratio is 121.46. Revenue is $795.49M.
| Metric | Value |
|---|---|
| Price | $62.16 |
| Market Cap | $989.83M |
| P/E Ratio | 121.46 |
| EPS | $0.51 |
| Dividend Yield | 0.46% |
| 52-Week High | $101.20 |
| 52-Week Low | $58.19 |
| Volume | 184.99K |
| Avg Volume | 0 |
| Revenue (TTM) | $795.49M |
| Net Income | $52.69M |
| Gross Margin | 19.03% |
| Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $780.99M | $58.01M | $1.42 |
| 2023 | $604.80M | $37.22M | $1.28 |
| 2022 | $553.14M | $43.41M | $2.25 |
| 2021 | $495.02M | $57.92M | $2.41 |
6 analysts cover USPH: 0 strong buy, 5 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $97.50.